Parasitic

Main information

  • Trade name:
  • Parasitic infectious diseases IVDs
  • Class:
  • - IVD Class 2
  • Medicine domain:
  • Humans
  • Medicine type:
  • Medical device

Documents

Localization

  • Available in:
  • Parasitic infectious diseases IVDs
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 216912
  • Last update:
  • 09-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

216912

Elitechgroup Australia PTY LTD - Parasitic infectious diseases IVDs

ARTG entry for

Medical Device Included - IVD Class 2

Sponsor

Elitechgroup Australia Pty Ltd

Postal Address

PO Box 576,BRAESIDE, VIC, 3195

Australia

ARTG Start Date

4/11/2013

Product category

Medical Device Class 2

Status

Active

Approval area

Conditions

- The inclusion of the kind of device in the ARTG is subject to compliance with all conditions placed or imposed on the ARTG entry. Refer Part 4-5,

Division 2 (Conditions) of the Therapeutic Goods Act 1989 and Part 5, Division 5.2 (Conditions) of the Therapeutic Goods (Medical Devices) Regulations

2002 for relevant information.

- Breaching conditions of the inclusion related to the device of the kind may lead to suspension or cancellation of the ARTG entry; may be a criminal

offence; and civil penalties may apply.

Manufacturers

Name

Address

EliTech Microbio

19 allee d'Athenes

Parc d'Activities du Plateau

, Signes, 83870

France

Products

1. Parasitic infectious diseases IVDs

Product Type

Effective date

4/11/2013

GMDN

CT356 Parasitic infectious diseases IVDs

Intended purpose

IVDs intended to be used in testing to provide information about the presence of, or infection with parasitic

organisms.

Specific Conditions

No Specific Conditions included on Record

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 10.11.2017 at 03:56:45 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

There are no safety alerts related to this product.

21-9-2018

Scientific guideline:  Reflection paper on resistance in ectoparasites, draft: consultation open

Scientific guideline: Reflection paper on resistance in ectoparasites, draft: consultation open

The Committee adopted a new draft reflection paper on ectoparasitic resistance (EMA/CVMP/EWP/310225/2014) for a 11-month period of public consultation. The reflection paper aims to give an overview of the currently known resistance situation in ectoparasites to active substances used in veterinary medicinal products with a special focus on Europe, and to provide a review of the current knowledge on resistance mechanisms.

Europe - EMA - European Medicines Agency